Pharmacovigilance — the science of detecting, assessing, and preventing adverse drug reactions — is one of the most critical and resource-intensive responsibilities in the pharmaceutical industry. Traditional manual case processing and periodic reporting cannot keep pace with the growing volume of real-world evidence, spontaneous reports, and regulatory demands under the EU AI Act. Leading Swiss pharma and life sciences companies are now deploying sovereign agentic pharmacovigilance systems that continuously monitor safety data in real time, automatically detect and classify adverse events, and generate compliant reports — all while keeping every piece of sensitive patient and safety data securely on Swiss infrastructure.
- Adverse event detection and case processing accelerated from days to minutes
- False positives reduced by up to 70% through intelligent multi-agent reasoning
- Full EU AI Act and Swissmedic compliance with built-in explainability
- Sovereign deployment on Exoscale SKS guarantees complete data residency
- Pharmacovigilance teams reclaim up to 65% of their time previously spent on manualreview
The Growing Burden of Traditional Pharmacovigilance
Manual case intake, signal detection, and periodic aggregate reporting create massive workloads and delay critical safety insights. With increasing regulatory scrutiny and the volume of real-world data exploding, legacy systems are no longer sustainable for Swiss pharma companies.
The Sovereign Agentic Pharmacovigilance Solution
A new generation of autonomous multi-agent systems is transforming safety monitoring. These sovereign agentic platforms continuously analyse spontaneous reports, electronic health records, social media signals, and clinical data to detect adverse events in real time — all running inside dedicated Swiss tenants on Exoscale SKS.
How the Multi-Agent System Works
Built with LangGraph orchestration, the solution coordinates specialised agents:
• Signal Detection & Ingestion Agent – processes incoming safety reports and real-world data using sovereign RAG
• Adverse Event Classification Agent – assesses seriousness, causality, and expectedness
• Regulatory Reporting Agent – automatically generates and submits compliant reports to Swissmedic and EMA
• Compliance & Audit Agent – ensures every action meets EU AI Act requirements and maintains full traceability
The entire workflow is fully auditable and remains 100% within Swiss borders.
Proven Results from Swiss Life Sciences Companies
Early deployments have delivered impressive outcomes:
• Adverse event processing time reduced from days to minutes
• Signal detection sensitivity improved while false positives dropped by up to 70%
• Pharmacovigilance operational costs reduced by 50–65%
• Full regulatory compliance achieved with explainable AI outputs
• Faster safety insights leading to earlier risk mitigation
Why Sovereignty Is Non-Negotiable for Pharmacovigilance
Adverse event and patient safety data are among the most sensitive information in the pharmaceutical industry. Foreign cloud solutions cannot meet the strict data residency and regulatory control requirements that Swiss companies must satisfy. Sovereign agentic platforms deliver both world-class safety monitoring and full Swiss compliance.
